Purdue Pharma (“Purdue”) has received a patent for a medication to treat opioid addiction, meaning the company’s former president stands to benefit financially from the opioid crisis. Purdue was granted a patent for a new version of the addiction treatment drug buprenorphine. The patent is for a wafer, which will dissolve a few seconds after … Continue reading “OxyContin Manufacturer Receives Patent for Opioid Treatment Drug”